Recent U.S. Customs and Border Protection rulings from CROSS, searchable by HTS code, keyword, or ruling number.
In your letter dated September 9, 2026, you requested a tariff classification ruling. Diltiazem Hydrochloride, imported in 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg extended-release capsules, is in a class of medications called calcium-channel blockers. It is indicated for the treatment of hypertension (high blood pressure) and to manage chronic stable angina.
In your letter dated September 9, 2026, you requested a tariff classification ruling. Linezolid, imported in 600 mg tablets, is in a class of antibacterials called oxazolidinones. It is indicated for the treatment of infections caused by susceptible strains of Gram-positive bacteria. The applicable subheading for the Linezolid Tablets in dosage form will be 3004.90.9214, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for...
In your letter dated September 9, 2026, you requested a tariff classification ruling. Norepinephrine Bitartrate, imported in 4 mg/4 mL vials, is a vasopressor indicated to raise blood pressure in adult patients with severe, acute hypotension and as an adjunct treatment during cardiac arrest. In your letter, you stated the country of origin of Norepinephrine Bitartrate is Italy and exported from India.
In your letter dated August 21, 2026, you requested a tariff classification ruling. Fulvestrant Injection, imported in 250 mg/5 mL syringes, is an estrogen receptor antagonist. It is indicated for the treatment of hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy.
In your letter dated August 21, 2026, you requested a tariff classification ruling. Fulvestrant Injection, imported in 250 mg/5 mL syringes, is an estrogen receptor antagonist. It is indicated for the treatment of hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy.
In your letter dated August 20, 2026, you requested a tariff classification ruling. Ranolazine Extended-Release Tablets is an anti-anginal drug indicated for the treatment of chronic angina. It works primarily by inhibiting the late inward sodium current in heart muscle cells, which prevents intracellular calcium overload and reduces cardiac wall tension without altering heart rate or blood pressure.
In your letter dated August 20, 2026, you requested a tariff classification ruling. Bupropion Hydrochloride, imported in extended-release tablets, is a norepinephrine-dopamine reuptake inhibitor. It is indicated for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD).
In your letter dated July 8, 2026, on behalf of Boston Medical Products Inc., you requested a tariff classification ruling. Steritalc powder, imported in 2 g, 3 g, and 4 g vials, is a sclerosing agent. It is intended for intrapleural administration (insufflation into the pleural cavity) for the treatment of malignant pleural effusions and pneumothorax.
In your letter dated July 8, 2026, you requested a tariff classification ruling. Famotidine Oral Suspension, imported in 40 mg/5 mL, is a histamine H2 receptor antagonist. It is indicated for the treatment of active duodenal ulcer (DU), active gastric ulcer (GU), symptomatic nonerosive gastroesophageal reflux disease (GERD), erosive esophagitis due to GERD, and Zollinger-Ellison syndrome.
In your letter dated July 8, 2026, you requested a tariff classification ruling. Progesterone, imported in 100 mg and 200 mg capsules, is in a class of medications called progestins. It is indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. It is also indicated for use in secondary amenorrhea. In your letter, you stated the country of origin is China and exported out of India.
In your letter dated July 8, 2026, you requested a tariff classification ruling. Fosfomycin Tromethamine, imported in 3 gram granules for oral solution, is a synthetic broad-spectrum antibiotic. It is only indicated for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis.
In your letter dated June 18, 2026, you requested a tariff classification ruling. Pantoprazole Sodium, imported in 20 mg, and 40 mg delayed-release tablets, belongs to a class of medications called proton pump inhibitors (PPIs). It is indicated for the treatment of erosive esophagitis, gastric acid hypersecretion, and to promote healing of tissue damage caused by gastric acid.
In your letter dated May 28, 2026, you requested a tariff classification ruling. Tadalafil, imported in dosages of 2.5 mg, 5 mg, 10 mg and 20 mg tablets, is a phosphodiesterase 5 (PDE5) inhibitor. It is primarily indicated for the treatment of erectile dysfunction. It is also indicated for the treatment of benign prostatic hyperplasia, and pulmonary arterial hypertension.
In your letter dated April 7, 2026, you requested a tariff classification ruling. Colestipol Hydrochloride, imported in 1 gram tablets, is a bile acid sequestrant. It is indicated for use as an adjunct to diet and exercise to reduce LDL-C cholesterol levels in patients with primary hypercholesterolemia.
In your letter dated April 7, 2026, you requested a tariff classification ruling. Glucagon Injection, imported in 1 mg vials, is a polypeptide hormone. It is primarily indicated for the treatment of patients with severe hypoglycemia. It is also used in diagnostic tests to temporarily inhibit movement of the gastrointestinal tract during certain radiologic procedures. In your letter, you stated the country of origin is Switzerland and exported from India.
In your letter dated April 6, 2026, you requested a tariff classification ruling. Brivaracetam Oral Solution, imported in 10 mg/mL, is an anticonvulsant drug. It is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. The applicable subheading for the Brivaracetam Oral Solution in dosage form will be 3004.90.9243, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other:...
In your letter dated April 2, 2026, you requested a tariff classification ruling. Sugammadex Injection, imported in 200 mg/2 mL (100 mg/mL), is a selective relaxant binding agent. It is indicated for the reversal of neuromuscular blockades induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.
In your letter dated April 1, 2026, you requested a tariff classification ruling. Doxorubicin Hydrochloride Liposome Injection, imported in dosages of 20 mg/10 mL and 50 mg/25 mL vials, is a cytotoxic anthracycline antibiotic. It is indicated for the treatment of patients with ovarian cancer, AIDS-related Kaposi’s sarcoma, and in combination with bortezomib in patients with multiple myeloma.
In your letter dated March 31, 2026, you requested a tariff classification ruling. Bumetanide, imported in 0.5 mg, 1 mg, and 2 mg tablets, belongs to a class of medications called loop diuretics. It is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal diseases, including nephrotic syndrome. In your letter you stated the country of origin is Spain and exported out of India.
In your letter dated March 31, 2026, you requested a tariff classification ruling. Bumetanide, imported in 0.5 mg, 1 mg, and 2 mg tablets, belongs to a class of medications called loop diuretics. It is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal diseases, including nephrotic syndrome. In your letter, you stated the country of origin is Italy and exported out of India.
In your letter dated March 31, 2026, you requested a tariff classification ruling. Bumetanide, imported in 1 mg and 2 mg tablets, belongs to a class of medications called loop diuretics. It is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal diseases, including nephrotic syndrome.
In your letter dated March 30, 2026, you requested a tariff classification ruling. Brimonidine Tartrate and Timolol Maleate Ophthalmic Drops, imported in 5 mL, 10 mL, and 15 mL, is a combination medication containing, Brimonidine Tartrate (an alpha-2 adrenergic receptor agonist) and Timolol Maleate (a beta-adrenergic receptor blocker), as the active ingredients. It is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP.
Source: rulings.cbp.gov (CROSS). This index holds New York rulings from the recent period and the Headquarters rulings they cite. It is not the full CROSS database of 222,467 rulings, and it does not hold every Headquarters ruling. New rulings usually appear here within a few days of CBP publishing them; a ruling published long after its number was assigned can take several weeks. A ruling is marked revoked or modified only when an indexed Headquarters ruling says so, so the absence of a mark is not confirmation that a ruling is still in effect. A ruling letter is binding on CBP only for the particular transaction or issue it describes (19 CFR 177.9). Confirm the text and status on CROSS before relying on a ruling. Not legal advice.